Reference
Alabdulwahab AS, et al. The Dana Farber consortium protocol (DFCP) vs. classic Hyper-CVAD for treatment of acute lymphoblastic leukemia in patients < 50 Y. Single institution experience. Leukemia Research 60: 58-62, Sep 2017. Available from: URL: http://doi.org/10.1016/j.leukres.2017.06.010 - Saudi Arabia
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1667, 33 (2017). https://doi.org/10.1007/s40278-017-35165-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-35165-2